dr donna h ryan glp 1 Pharmacy Focus: GLP-1 Medications and Pharmacists' Role in Counseling Patients CRS 2017: Cardiometabolic Disease and
Description
The FDA has laid out post-marketing safety testing requirements for Lilly's weight-loss pill Foundayo, including clinical trials.
Tirzepatide and injectable semaglutide were associated with the greatest weight loss after a year of treatment among several GLP-1 receptor agonists, a recent study showed.“Despite being the most recent medication approved for weight loss, tirzepatide [Zepbound, Eli Lilly] showed the greatest weight loss among the GLP-1 medications studied,&rdquo
Read more about GLP-1 Studies: Tani, Y., Tokuda, M., Nishimoto, N., Yokoi, H., & Izumori, K
Setting UK Clinical Practice Research Datalink linked to Hospital Episode Statistics Admitted Patient Care and Office for National Statistics databases
Originally developed and positioned as treatments for type 2 diabetes, these agents are now equally associated with weight management, reshaping how clinicians, patients, and pharmacies understand metabolic disease
They both help control appetite and support steady weight loss
